prospect
hospitalbas
multicent
casecontrol
studi
incid
case
implement
may
june
member
site
gabriel
global
approach
biolog
research
infecti
diseas
epidem
lowincom
countri
network
countri
cambodia
nation
pediatr
hospit
phnom
penh
china
beij
children
hospit
beij
haiti
tent
citi
hospit
portauprinc
india
pune
site
kem
hospit
research
center
shirdi
sai
baba
rural
hospit
lucknow
site
chatrapati
shahuji
maharaj
univers
hospit
madagascar
antananarivo
mali
gabriel
hospit
bamako
mongolia
bayanzurkh
district
gener
hospit
ulaanbaatar
paraguay
hospit
de
acosta
san
lorenzo
studi
protocol
inform
consent
statement
case
report
form
amend
studi
document
approv
local
institut
research
ethic
committe
supplementari
materi
databas
anonym
elig
patient
identifi
studi
clinician
site
consecut
hospit
patient
assess
elig
everi
season
least
year
pneumonia
case
fulfil
inclus
criteria
hospit
patient
age
month
present
cough
andor
dyspnea
tachypnea
defin
world
health
organ
breath
rate
cyclesminut
month
age
cyclesminut
month
age
first
symptom
appear
last
day
radiolog
confirm
primari
endpoint
pneumonia
follow
guidelin
inform
consent
statement
sign
parent
legal
guardian
primari
endpoint
pneumonia
confirm
least
medic
reader
studi
site
presenc
endpoint
consolid
chest
radiograph
pleural
effus
later
pleural
space
associ
pulmonari
parenchym
infiltr
effus
larg
enough
obscur
opac
wheez
initi
exclus
criterion
case
withdrawn
countri
creat
difficulti
enrol
patient
inclus
criteria
control
signssymptom
respiratori
illnessupp
respiratori
tract
infect
month
age
hospit
surgeri
attend
routin
outpati
appoint
mild
ill
routin
monitor
immun
etc
hospit
site
inform
consent
sign
parent
legal
guardian
origin
plan
includ
control
per
case
match
age
vs
month
date
admiss
month
goal
achiev
countri
overal
individu
match
frequencymatch
pool
analysi
perform
site
age
period
admiss
nasopharyng
swab
collect
use
flexibl
minitip
flock
swab
copan
diagnost
murrieta
california
individu
within
hour
admiss
process
similarli
site
nineteen
virus
bacteria
detect
use
reversetranscript
polymeras
chain
reaction
rtpcr
fasttrack
diagnost
respiratori
pathogen
plu
luxembourg
central
blind
qualiti
control
pcr
respiratori
valid
panel
provid
site
specimen
process
local
urin
whole
blood
pleural
effus
case
pleurisi
collect
case
within
hour
admiss
urin
sampl
subject
antibiot
test
whole
blood
subject
blood
count
blood
cultur
rtpcr
identifi
staphylococcu
aureu
pneumonia
hib
serum
creactiv
protein
crp
procalcitonin
pct
pleural
effus
process
respiratori
specimen
systemat
hiv
screen
hivinfect
children
known
seroposit
statu
admiss
pool
analysi
aim
includ
case
control
yield
power
detect
odd
ratio
or
exposur
control
regardless
exposur
preval
case
categor
variabl
report
number
percentag
compar
use
test
continu
variabl
report
mean
standard
deviat
sd
median
interquartil
rang
iqr
student
test
analysi
varianc
uncondit
regress
perform
partial
match
increas
power
gener
effici
multivari
logist
regress
use
quantifi
associ
microorgan
detect
nasopharyng
swab
pneumonia
risk
multivari
model
first
adjust
sex
age
categori
time
period
per
quarter
site
addit
adjust
microorgan
detect
nasopharyng
swab
stratifi
age
categori
use
separ
model
final
multivari
logist
model
undertaken
site
adjust
sex
age
categori
time
period
microorgan
adjust
popul
attribut
fraction
apaf
calcul
upper
respiratori
sampl
blood
rtpcr
data
avail
control
conceptu
apaf
estim
proport
reduct
individu
pathogen
absent
calcul
punafcc
function
stata
use
adjust
aor
multivari
model
adjust
pathogen
test
pool
analysi
site
agestratifi
analysi
among
pneumonia
case
posit
particular
pathogen
proport
diseas
attribut
background
rate
attribut
risk
fraction
fraction
pneumonia
case
attribut
pathogen
apaf
given
proport
case
posit
pathogen
multipli
attribut
risk
fraction
supplementari
materi
sensit
analys
assess
put
select
bia
multivari
logist
model
perform
calcul
apaf
exclud
site
individu
site
time
exclud
case
wheez
antibiot
detect
urin
test
p
consid
signific
statist
analysi
perform
use
stata
softwar
version
stata
corp
colleg
station
texa
miss
data
avoid
perform
complet
case
analysi
respiratori
sampl
sampl
characterist
miss
data
includ
describ
elig
children
patient
pneumonia
case
control
analyz
figur
proport
individu
exclud
reassess
inclus
criteria
rang
mongolia
paraguay
china
overal
children
male
mean
age
sd
month
nineteen
patient
hivinfect
tabl
describ
studi
popul
characterist
group
site
identifi
imbal
case
control
season
countri
therefor
multivari
analys
adjust
season
pneumonia
case
lower
weightforheight
z
score
p
vaccin
coverag
p
tabl
among
case
wheez
test
posit
urinari
antibiot
admiss
receiv
oxygen
therapi
admiss
median
bodi
temperatur
iqr
median
breath
rate
cyclesminut
iqr
cyclesminut
median
serum
crp
mgl
iqr
mgl
median
serum
pct
ngml
iqr
ngml
median
white
blood
cell
count
cellsl
iqr
cellsl
nasopharyng
sampl
microorgan
detect
case
control
p
bacteria
case
control
p
viru
case
control
p
mix
viralbacteri
detect
case
control
p
case
differ
observ
respect
sex
age
categori
weightforheight
z
score
pcv
vaccin
rate
serum
pct
serum
crp
inhospit
mortal
accord
type
infect
detect
nasopharyng
swab
viral
bacteri
mix
viralbacteri
streptococcu
pneumonia
mycoplasma
pneumonia
human
metapneumoviru
hmpv
rhinoviru
rsv
parainfluenza
viru
influenza
viru
b
independ
associ
pneumonia
risk
tabl
supplementari
tabl
influenza
viru
strongli
associ
aor
confid
interv
ci
follow
hmpv
rsv
aor
ci
ci
respect
streptococcu
pneumonia
h
influenza
posit
associ
howev
associ
weaker
vari
age
tabl
supplementari
tabl
blood
rtpcr
case
posit
pneumonia
h
influenza
aureu
respect
eighti
case
posit
blood
cultur
possibl
attribut
bacteri
contamin
salmonella
speci
n
pneumonia
n
aureu
n
hib
n
acinetobact
baumannii
n
enterobact
cloaca
n
enterococcu
faecium
n
escherichia
coli
n
neisseria
meningitidi
n
gramposit
bacilli
n
detect
blood
cultur
among
case
posit
blood
cultur
also
posit
speci
pneumonia
aureu
hib
respect
blood
pcr
pleural
sampl
obtain
case
microorgan
detect
pneumonia
n
aureu
n
adenoviru
n
bocaviru
n
case
posit
pneumonia
blood
rtpcr
posit
speci
respiratori
sampl
p
case
pcr
posit
pneumonia
pleural
respiratori
sampl
streptococcu
pneumonia
highest
apaf
ci
pool
analysi
valu
consist
regardless
age
tabl
supplementari
figur
rsv
secondhighest
apaf
invers
relationship
observ
rsv
pneumonia
age
rhinoviru
third
highest
apaf
independ
associ
pneumonia
younger
children
month
streptococcu
pneumonia
main
bacterium
associ
pneumonia
countri
except
cambodia
china
india
lucknow
site
figur
rsv
hmpv
also
signific
agent
pathogen
select
coupl
pneumonia
countri
apaf
valu
vari
mostli
within
individu
site
exclud
supplementari
figur
exclus
case
wheez
antibioticposit
urin
substanti
affect
estim
except
rsv
antibioticposit
case
exclud
supplementari
figur
prospect
multicent
casecontrol
studi
identifi
microorgan
associ
pneumonia
children
year
old
develop
emerg
countri
low
pcv
coverag
streptococcu
pneumonia
hmpv
rhinoviru
rsv
parainfluenza
viru
influenza
viru
b
mycoplasma
pneumonia
associ
pneumonia
risk
independ
sex
age
time
period
detect
pathogen
site
streptococcu
pneumonia
highest
apaf
detect
pneumonia
respiratori
sampl
case
indic
infect
colon
pneumococc
carriag
link
sever
risk
factor
includ
age
famili
size
model
account
age
site
sex
time
period
residu
confound
may
exist
pneumococci
commonli
recogn
primari
etiolog
pneumonia
pneumococcu
vaccin
dramat
decreas
incid
pediatr
pneumonia
caus
pneumonia
unit
state
recent
introduc
sever
develop
emerg
countri
countri
introduc
pcv
decemb
year
ago
countri
howev
countri
would
achiev
coverag
pcv
vaccin
therefor
prevent
measur
prioriti
pcv
coverag
higher
control
studi
design
analyz
vaccin
effect
radiograph
criteria
pneumonia
defin
robust
endpoint
pcv
hib
vaccin
trial
may
bia
result
toward
bacteri
caus
viral
pneumonia
less
like
present
lobar
consolid
effus
howev
aim
focu
primarili
sever
pneumonia
requir
hospit
studi
site
low
pcv
vaccin
coverag
epidemiolog
may
vari
develop
countri
higher
vaccin
coverag
would
use
reassess
pneumonia
etiolog
year
evalu
impact
pcv
vaccin
rsv
main
viral
agent
associ
pneumonia
apaf
consist
previou
metaanalysi
show
rsv
caus
acut
lower
respiratori
infect
rsv
detect
decreas
age
accord
recent
find
set
differ
sourc
popul
case
definit
popul
rhinoviru
significantli
associ
pneumonia
high
detect
rate
control
rhinoviru
detect
american
children
hospit
communityacquir
pneumonia
debat
grow
evid
suggest
causal
role
rhinoviru
pneumonia
etiolog
human
metapneumoviru
may
also
import
describ
common
respiratori
pathogen
children
particularli
year
age
account
pediatr
acut
respiratori
infect
hospit
though
frequent
describ
agent
haemophilu
influenza
significantli
associ
pneumonia
high
hib
vaccin
coverag
could
explain
find
apaf
wide
employ
chronic
diseas
rare
infecti
diseas
base
paramet
preval
test
posit
among
case
odd
ratio
interpret
infecti
diseas
epidemiolog
less
demonstr
addit
pneumonia
investig
includ
control
group
account
carriag
preval
imperfect
test
thu
detect
sever
microorgan
nasopharyng
sampl
confirm
caus
role
blood
rtpcr
result
includ
apaf
estim
prevent
inform
bia
upper
respiratori
specif
enough
diagnos
etiolog
individu
level
sampl
distant
diseas
help
infer
pneumonia
etiolog
popul
level
approach
seek
control
caus
incid
complementari
casecent
epidemiolog
may
guid
global
prevent
strategi
multivari
model
adjust
pathogen
test
mean
pathogen
significantli
significantli
associ
pneumonia
retain
nonsignific
result
microorgan
suggest
lack
power
detect
weak
associ
effect
chanc
ie
relat
studi
sampl
bia
advanc
molecular
diagnost
tool
may
use
epidemiolog
purpos
though
imperfect
sensit
specif
may
induc
confus
carriag
infect
miss
true
infect
viral
agent
detect
upper
respiratori
sampl
consist
often
case
control
site
low
detect
rate
control
howev
detect
virus
bacteria
use
molecular
diagnost
tool
contribut
littl
clinic
manag
addit
sensit
nasopharyng
swab
like
higher
pneumonia
case
larger
mucou
volum
due
symptom
coryza
main
strength
studi
includ
prospect
collect
standard
data
advanc
molecular
diagnost
techniqu
difficulti
encount
relat
multicultur
context
project
enabl
construct
decentr
infecti
diseas
research
network
develop
countri
multicentr
design
inclus
countri
bear
major
global
pneumonia
burden
would
permit
gener
result
develop
countri
identifi
similar
lead
pathogen
across
countri
multivari
analysi
account
baselin
level
carriag
control
estim
independ
contribut
pathogen
howev
residu
confound
might
persist
sensit
respiratori
sampl
vari
depend
microorgan
among
pathogen
strong
posit
associ
eg
pneumonia
rsv
hmpv
adjust
increas
suggest
pathogen
may
protect
simultan
associ
index
pathogen
pathogen
may
pneumonia
risk
neg
associ
pathogen
describ
aureu
pneumonia
final
despit
exclus
patient
respiratori
sign
control
analys
permit
adjust
respiratori
carriag
noninfect
children
limit
includ
limit
power
track
season
differ
site
sampl
size
rel
small
estim
sitespecif
differ
number
case
vari
site
could
lead
geograph
confound
howev
pool
analys
adjust
studi
site
second
case
definit
amend
due
difficulti
enrol
patient
without
wheez
could
jeopard
intern
valid
howev
data
remain
robust
sensit
analys
success
exclud
individu
site
case
wheez
sensit
analysi
exclus
case
prehospit
antibiot
exposur
suggest
import
pneumonia
rsv
pneumonia
might
underestim
rhinoviru
overestim
season
enrol
discrep
observ
site
although
multivari
model
adjust
potenti
limit
residu
cofound
might
persist
public
larg
pneumonia
etiolog
research
child
health
perch
studi
help
assess
valid
causal
studi
addit
possibl
higher
detect
rate
pneumonia
possibl
patient
coryza
would
lead
misclassif
bia
regard
bacterium
inde
may
easier
identifi
nucleic
acid
respiratori
sampl
volumin
final
although
causal
difficult
approach
result
consist
estim
prepcv
popul
children
year
old
develop
emerg
countri
almost
half
pneumonia
case
may
attribut
pneumonia
major
virus
associ
pneumonia
rsv
rhinoviru
hmpv
addit
longitudin
studi
could
test
larger
number
bacteria
account
poor
sensit
blood
cultur
increas
pneumonia
vaccin
coverag
would
substanti
reduc
pneumonia
burden
develop
emerg
countri
therapeut
measur
consid
